Literature DB >> 6877446

Pseudothrombocytopenia and IgA-related platelet agglutinin in a patient with IgA nephritis.

H Imai, Y Nakamoto, K Miki, T Miyakuni, A B Miura.   

Abstract

A 41-year-old female was evaluated for asymptomatic proteinuria and thrombocytopenia. The renal biopsy disclosed mild to moderate mesangial proliferation, and the immunohistology showed granular deposition of dominant IgA and C3 in the mesangium, which is consistent with IgA nephritis. Thrombocytopenia was EDTA-dependent pseudothrombocytopenia type 1. Heparinized blood restored the platelet count to normal. Serological examinations revealed that the platelet agglutinin was IgA, and the platelet clumping required both EDTA and IgA-related agglutinin. Thus, the present case adds the combination of IgA nephritis and pseudothrombocytopenia to the spectrum of the so-called thromborenal syndrome. In view of recent findings that platelet agglutinins belong to immunoglobulins or fractions, occurring frequently in a variety of immunologically abnormal situations, IgA-related agglutinin as seen in this patient may have more than a chance association with IgA nephritis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6877446     DOI: 10.1159/000183001

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  3 in total

1.  In vivo alteration of antibody production in patients with IgA nephropathy.

Authors:  M Endoh; T Suga; M Miura; Y Tomino; Y Nomoto; H Sakai
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

2.  EDTA dependent pseudothrombocytopenia caused by antibodies against the cytoadhesive receptor of platelet gpIIB-IIIA.

Authors:  A Casonato; A Bertomoro; E Pontara; D Dannhauser; A R Lazzaro; A Girolami
Journal:  J Clin Pathol       Date:  1994-07       Impact factor: 3.411

3.  Transient appearance of EDTA-dependent pseudothrombocytopenia in a postoperative patient with sepsis: A case report.

Authors:  Xiang Shi; Zhongyuan Lin; Liyan He; Wenchao Li; Lijun Mo; Yinyin Li; Zheng Yang; Wu-Ning Mo
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.